Global Cord Blood (NYSE:CO) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO) in a note issued to investors on Tuesday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Stock Down 43.5 %

Shares of CO opened at $0.65 on Tuesday. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50. The company’s fifty day moving average is $0.95 and its two-hundred day moving average is $1.18. The firm has a market cap of $79.01 million, a PE ratio of 1.02 and a beta of 0.16.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.